Comparing microwave ablation and liver surgery for treating intrahepatic cholangiocarcinoma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of microwave ablation (MWA) compared to liver resection (LR) in patients with intrahepatic cholangiocarcinoma (iCCA). It will analyze survival outcomes and identify risk factors associated with both treatment methods. Data will be collected from multiple hospitals for patients who meet specific criteria, focusing on those with tumors within the Milan criteria. The study seeks to determine if MWA can serve as a viable first-line treatment option for iCCA.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. pathologically diagnosed iCCA based on the WHO classifications;
2. curative-intent liver resection or microwave ablation;
3. tumor within Milan criteria, namely single tumor ≤5cm in maximum diameter; multiple tumors ≤3 in number and each ≤3cm; no evidence of major vascular/hilar invasion, extrahepatic/lymphatic metastasis or other malignancies;
4. age ≥18 years.

Exclusion Criteria:

Patients not meeting any one of the inclusion criteria were excluded.

Where it's running

• Chinese PLA General Hospital
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: Chuan Pang, Doctor
• Email: pcpang117@163.com
• Phone: +86-18910527022

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term follow-up for patients treated with CAR T cells

  This study looks at how well CAR T cell therapy works and its long-term safety for patients up to 15 years after their treatment.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT05024175

• Dose-adjusted EPOCH infusions for frail adults with acute lymphoblastic leukemia

  This project will see if a dose-adjusted, infusion-based EPOCH chemotherapy regimen helps frail adults with acute lymphoblastic leukemia tolerate treatment better and live longer.

  Recruiting Hospital General de Mexico · Mexico City, Mexico City · NCT07258043

• Navigating lung nodules for resection using a new mapping technique

  This study is testing a new way to locate small lung nodules during surgery to see if it helps patients with early-stage lung cancer recover faster and have better outcomes.

  Recruiting Guangdong Provincial People's Hospital · Guangzhou, Guangdong · NCT06404164

• New target method for treating high-grade glioma patients

  This study tests a new way of targeting radiation treatment for patients with high-grade glioma to see if it helps them live longer without their cancer getting worse and reduces side effects compared to the standard method.

  Recruiting Zhujiang Hospital · Guangzhou · NCT06215495

• Reduced intensity conditioning for older patients with myeloid malignancies

  This study is testing a gentler treatment plan for older patients with blood cancers to see if it helps them live longer and healthier after a stem cell transplant.

  Recruiting at 2 sites Phase 2 Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality and 1 other locations · NCT05436561

• Managing blood pressure and using dexamethasone during lung cancer surgery

  This study is testing if managing blood pressure and giving dexamethasone during lung cancer surgery can help patients recover better and live longer.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT04209218

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.